GB1547758A
(en)
|
1975-07-29 |
1979-06-27 |
Shell Int Research |
Herbicidal composition
|
JPH01261381A
(ja)
|
1988-04-12 |
1989-10-18 |
Nippon Soda Co Ltd |
オキサ(チア)ジアゾール誘導体、その製造方法及び殺ダニ剤
|
FR2693461B1
(fr)
|
1992-07-08 |
1994-09-02 |
Roussel Uclaf |
Nouvelles phénylimidazolidines substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
|
US5411981A
(en)
|
1991-01-09 |
1995-05-02 |
Roussel Uclaf |
Phenylimidazolidines having antiandrogenic activity
|
US5589452A
(en)
|
1992-07-14 |
1996-12-31 |
Syntex (U.S.A.) Inc. |
Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
|
GB9310635D0
(en)
|
1993-05-21 |
1993-07-07 |
Glaxo Group Ltd |
Chemical compounds
|
DE19517430A1
(de)
|
1995-05-12 |
1996-11-14 |
Boehringer Mannheim Gmbh |
Pharmazeutische Darreichungsform von Parathormon mit einer zwei- bis sechsstündigen Wirkstoff-Freisetzungsperiode
|
UA51652C2
(uk)
|
1995-06-08 |
2002-12-16 |
Новартіс Аг |
Спосіб гідрування імінів
|
US5969095A
(en)
|
1995-07-13 |
1999-10-19 |
Biomeasure, Inc. |
Analogs of parathyroid hormone
|
US7410948B2
(en)
|
1995-07-13 |
2008-08-12 |
Societe De Conseils De Recherches Et D'applications Scientifiques, Sas |
Analogs of parathyroid hormone
|
US5955574A
(en)
|
1995-07-13 |
1999-09-21 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. |
Analogs of parathyroid hormone
|
US6544949B1
(en)
|
1995-07-13 |
2003-04-08 |
Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. |
Analogs of parathyroid hormone
|
US5723577A
(en)
|
1995-07-13 |
1998-03-03 |
Biomeasure Inc. |
Analogs of parathyroid hormone
|
JP2000513362A
(ja)
|
1996-06-27 |
2000-10-10 |
リガンド・ファーマスーティカルス・インコーポレーテッド |
アンドロゲン受容体モジュレーター化合物及び方法
|
US20090264534A1
(en)
|
1996-11-27 |
2009-10-22 |
Dalton James T |
Selective androgen receptor modulators
|
FR2770842B1
(fr)
|
1997-11-13 |
1999-12-17 |
Oreal |
Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
|
EP0922467A3
(en)
|
1997-12-12 |
2000-05-24 |
Takeda Chemical Industries, Ltd. |
Iontophoretic drug delivery
|
JP4154017B2
(ja)
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6159959A
(en)
|
1999-05-06 |
2000-12-12 |
American Home Products Corporation |
Combined estrogen and antiestrogen therapy
|
AU1280701A
(en)
|
1999-11-17 |
2001-05-30 |
Novartis Ag |
Iontophoretic transdermal delivery of peptides
|
US6544553B1
(en)
*
|
1999-12-28 |
2003-04-08 |
Watson Pharmaceuticals, Inc. |
Dosage forms and methods for oral delivery of progesterone
|
IL150463A0
(en)
|
1999-12-30 |
2002-12-01 |
Signal Pharm Inc |
Compounds and methods for modulation of estrogen receptors
|
PL357163A1
(en)
|
2000-01-28 |
2004-07-26 |
Endorecherche, Inc. |
Selective estrogen receptor modulators in combination with estrogens
|
US6960474B2
(en)
|
2000-06-28 |
2005-11-01 |
Bristol-Myers Squibb Company |
Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
|
AU8206401A
(en)
|
2000-08-03 |
2002-02-18 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
EA014224B1
(ru)
|
2000-08-24 |
2010-10-29 |
Юниверсити Оф Теннесси Рисерч Фаундейшн |
Селективные модуляторы андрогенового рецептора и способы их применения
|
US7186683B2
(en)
|
2000-09-18 |
2007-03-06 |
Sanos Bioscience A/S |
Use of GLP for the treatment, prevention, diagnosis, and prognosis of bone-related and nutrition-related disorders
|
US7371721B2
(en)
|
2000-09-18 |
2008-05-13 |
Sanos Bioscience A/S |
Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes
|
JP4659336B2
(ja)
|
2000-10-26 |
2011-03-30 |
アルザ・コーポレーシヨン |
被覆された微細突出物を有する経皮的薬剤配達装置
|
WO2003011824A1
(en)
|
2001-07-31 |
2003-02-13 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
EP1418900A4
(en)
|
2001-08-13 |
2006-01-25 |
Merck & Co Inc |
SELECTIVE ESTROGEN RECEPTOR MODULATORS
|
US8853266B2
(en)
|
2001-12-06 |
2014-10-07 |
University Of Tennessee Research Foundation |
Selective androgen receptor modulators for treating diabetes
|
WO2003063859A1
(en)
|
2002-01-14 |
2003-08-07 |
Nordic Bioscience A/S |
Suppression of cartilage degradation via the estrogen receptor
|
CA2474171A1
(en)
|
2002-02-15 |
2003-08-21 |
Endorecherche, Inc. |
Biphenil derivatives and their use as antiandrogenic agents
|
US7772433B2
(en)
|
2002-02-28 |
2010-08-10 |
University Of Tennessee Research Foundation |
SARMS and method of use thereof
|
AU2003237084C1
(en)
|
2002-04-24 |
2009-03-26 |
Merck Sharp & Dohme Corp. |
Estrogen receptor modulators
|
TW200407324A
(en)
|
2002-05-17 |
2004-05-16 |
Bristol Myers Squibb Co |
Bicyclic modulators of androgen receptor function
|
TW200307553A
(en)
|
2002-05-24 |
2003-12-16 |
Akzo Nobel Nv |
Treatment of post-menopausal complaints in breast cancer patients
|
AU2003251527A1
(en)
|
2002-06-13 |
2003-12-31 |
Beth Israel Deaconess Medical Center, Inc. |
Analogs of parathyroid hormone and pth-related protein as bone anabolic agents
|
WO2004007471A1
(ja)
|
2002-07-12 |
2004-01-22 |
Yamanouchi Pharmaceutical Co., Ltd. |
N−フェニル−(2r,5s)ジメチルピペラジン誘導体
|
KR20050044902A
(ko)
|
2002-08-12 |
2005-05-13 |
다케다 야쿠힌 고교 가부시키가이샤 |
축합 벤젠 유도체 및 용도
|
IL152574A
(en)
|
2002-10-31 |
2009-09-22 |
Transpharma Medical Ltd |
A system for passing through the skin of dry items or dried medicines
|
US8133505B2
(en)
|
2002-10-31 |
2012-03-13 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
US7662404B2
(en)
|
2002-10-31 |
2010-02-16 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
|
US7383084B2
(en)
|
2002-10-31 |
2008-06-03 |
Transpharma Medical Ltd. |
Transdermal delivery system for dried particulate or lyophilized medications
|
CA2504044A1
(en)
|
2002-11-01 |
2004-05-21 |
Merck & Co., Inc. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
UA79504C2
(en)
|
2002-11-07 |
2007-06-25 |
Organon Nv |
Indols for treating diseases associated with androgen receptors
|
US7632858B2
(en)
|
2002-11-15 |
2009-12-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
CA2512000C
(en)
*
|
2002-12-26 |
2011-08-09 |
Eisai Co., Ltd. |
Selective estrogen receptor modulator
|
JP2006523196A
(ja)
|
2003-03-11 |
2006-10-12 |
ニューロサーチ、アクティーゼルスカブ |
新規kcnqチャネルを調節する化合物及びその医薬用途
|
US20060142387A1
(en)
|
2003-06-10 |
2006-06-29 |
Rodolfo Cadilla |
Chemical compounds
|
WO2005000795A2
(en)
|
2003-06-10 |
2005-01-06 |
Smithkline Beecham Corporation |
Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
|
WO2005000309A2
(en)
|
2003-06-27 |
2005-01-06 |
Ionix Pharmaceuticals Limited |
Chemical compounds
|
FI20030958A0
(fi)
|
2003-06-27 |
2003-06-27 |
Orion Corp |
Uusia yhdisteitä
|
CA2530531A1
(en)
|
2003-06-30 |
2005-01-20 |
Alza Corporation |
Formulations for coated microprojections containing non-volatile counterions
|
EP1643978A1
(en)
*
|
2003-07-04 |
2006-04-12 |
Nycomed Danmark A/S |
Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
|
CA2537660A1
(en)
|
2003-09-10 |
2005-03-24 |
Merck & Co., Inc. |
17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
|
GB0324551D0
(en)
|
2003-10-21 |
2003-11-26 |
Karobio Ab |
Novel compounds
|
US20050124625A1
(en)
|
2003-10-21 |
2005-06-09 |
Salvati Mark E. |
Piperazine derivatives and their use as modulators of nuclear hormone receptor function
|
EP1680154B1
(en)
|
2003-10-31 |
2012-01-04 |
ALZA Corporation |
Self-actuating applicator for microprojection array
|
AU2004292954A1
(en)
|
2003-11-13 |
2005-06-09 |
Alza Corporation |
Composition and apparatus for transdermal delivery
|
US7256208B2
(en)
|
2003-11-13 |
2007-08-14 |
Bristol-Myers Squibb Company |
Monocyclic N-Aryl hydantoin modulators of androgen receptor function
|
US20070129409A1
(en)
|
2003-11-20 |
2007-06-07 |
Lain-Yen Hu |
Androgen receptor modulators
|
IL159273A0
(en)
|
2003-12-09 |
2004-06-01 |
Transpharma Medical Ltd |
Transdermal delivery system for sustained release of polypeptides
|
AU2003297904A1
(en)
|
2003-12-12 |
2005-07-14 |
University Of Maryland, Baltimore |
Immunomodulatory compounds that target and inhibit the py+3 binding site of tyrosene kinase p56 lck sh2 domain
|
CA2551737C
(en)
|
2004-01-07 |
2009-11-10 |
Endorecherche, Inc. |
Helix 12 directed steroidal pharmaceutical products
|
JP4909086B2
(ja)
|
2004-01-22 |
2012-04-04 |
イーライ リリー アンド カンパニー |
血管運動性症候の治療のための選択的エストロゲン受容体モジュレーター
|
IL160033A0
(en)
|
2004-01-25 |
2004-06-20 |
Transpharma Medical Ltd |
Transdermal delivery system for polynucleotides
|
US7820702B2
(en)
|
2004-02-04 |
2010-10-26 |
Bristol-Myers Squibb Company |
Sulfonylpyrrolidine modulators of androgen receptor function and method
|
US20050182105A1
(en)
|
2004-02-04 |
2005-08-18 |
Nirschl Alexandra A. |
Method of using 3-cyano-4-arylpyridine derivatives as modulators of androgen receptor function
|
WO2005085185A1
(en)
|
2004-03-03 |
2005-09-15 |
Smithkline Beecham Corporation |
Aniline derivatives as selective androgen receptor modulators
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7388027B2
(en)
|
2004-03-04 |
2008-06-17 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
US7625923B2
(en)
|
2004-03-04 |
2009-12-01 |
Bristol-Myers Squibb Company |
Bicyclic modulators of androgen receptor function
|
GB0405033D0
(en)
|
2004-03-05 |
2004-04-07 |
Karobio Ab |
Novel pharmaceutical compositions
|
WO2005090282A1
(en)
|
2004-03-12 |
2005-09-29 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds and methods
|
JP2007223901A
(ja)
|
2004-03-24 |
2007-09-06 |
Takeda Chem Ind Ltd |
複素環化合物およびその用途
|
WO2005099707A1
(en)
|
2004-04-08 |
2005-10-27 |
Merck & Co., Inc. |
17 beta-acetamide-4-azasteroids as androgen receptor modulators
|
TW200602317A
(en)
|
2004-04-23 |
2006-01-16 |
Akzo Nobel Nv |
Novel androgens
|
AU2005243240B2
(en)
|
2004-05-03 |
2012-03-15 |
Janssen Pharmaceutica N.V. |
Novel indole derivatives as selective androgen receptor modulators (SARMS)
|
WO2005108351A1
(en)
|
2004-05-11 |
2005-11-17 |
Pfizer Products Inc. |
Benzonitrile derivatives to treat musculoskeletal frailty
|
AU2005244734A1
(en)
|
2004-05-13 |
2005-12-01 |
Alza Corporation |
Apparatus and method for transdermal delivery of parathyroid hormone agents
|
US7268232B2
(en)
|
2004-05-17 |
2007-09-11 |
Acadia Pharmaceuticals Inc. |
Androgen receptor modulators and method of treating disease using the same
|
US20080119456A1
(en)
|
2004-05-29 |
2008-05-22 |
Trond Ulven |
Substituted Thiazoleacetic Acid as Crth2 Ligands
|
GEP20094851B
(en)
|
2004-06-07 |
2009-12-10 |
The Univ Of Tennessee Research Foundation |
Selective androgen receptor modulators and methods of use thereof
|
CA2579514A1
(en)
|
2004-09-10 |
2006-03-23 |
Janssen Pharmaceutica N.V. |
Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (sarms)
|
CN101072780B
(zh)
*
|
2004-09-20 |
2010-06-23 |
詹森药业有限公司 |
用作类固醇性激素受体调节剂的新的含杂原子的四环衍生物
|
AU2005292345B9
(en)
|
2004-09-30 |
2011-12-15 |
Janssen Pharmaceutica N.V. |
Novel benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
|
US8143425B2
(en)
|
2004-10-12 |
2012-03-27 |
Bristol-Myers Squibb Company |
Heterocyclic aromatic compounds useful as growth hormone secretagogues
|
EP1809275A1
(en)
|
2004-10-13 |
2007-07-25 |
Smithkline Beecham Corporation |
Chemical compounds
|
EP1807076A4
(en)
|
2004-10-29 |
2010-06-02 |
Merck Sharp & Dohme |
N- (PYRIDIN-3-YL) -2-PHENYLBUTANAMIDES AS ANDROGEN RECEPTOR MODULATORS
|
AU2005307003B2
(en)
|
2004-11-16 |
2011-10-13 |
Janssen Pharmaceutica N.V. |
Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMs)
|
EP1848498A4
(en)
|
2004-11-18 |
2009-12-16 |
Transpharma Medical Ltd |
ASSOCIATED MICRO-CHANNEL PRODUCTION AND IONTOPHORESIS FOR TRANSDERMAL DELIVERY OF PHARMACEUTICAL AGENTS
|
EP1824821A2
(en)
|
2004-11-23 |
2007-08-29 |
PTC Therapeutics, Inc. |
Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
|
CN101119993B
(zh)
|
2005-01-10 |
2015-03-04 |
阿卡蒂亚药品公司 |
作为选择性雄激素受体调节剂的氨基苯基衍生物
|
EP1871379A4
(en)
|
2005-04-15 |
2010-06-02 |
Glaxosmithkline Llc |
CYANOARYLAMINE
|
MX2007014053A
(es)
|
2005-05-13 |
2008-02-05 |
Lilly Co Eli |
N-arilpirrolidinas substituidas como moduladores selectivos de receptor de androgeno.
|
US20090170907A1
(en)
|
2005-06-06 |
2009-07-02 |
Smithkline Beecham Corporation |
Chemical Compounds
|
US7829589B2
(en)
|
2005-06-10 |
2010-11-09 |
Elixir Pharmaceuticals, Inc. |
Sulfonamide compounds and uses thereof
|
US7709516B2
(en)
|
2005-06-17 |
2010-05-04 |
Endorecherche, Inc. |
Helix 12 directed non-steroidal antiandrogens
|
DE602006012322D1
(de)
|
2005-06-24 |
2010-04-01 |
Lilly Co Eli |
Als androgen-rezeptor-modulatoren verwendbare tetrahydrocarbazol-derivate
|
WO2007005887A2
(en)
|
2005-07-01 |
2007-01-11 |
Ligand Pharmaceuticals Incorporated |
Androgen receptor modulator compounds, compositions and uses thereof
|
EP1911743B8
(en)
|
2005-08-01 |
2013-01-16 |
Takeda Pharmaceutical Company Limited |
Cyclic amine compound
|
JP2008303145A
(ja)
|
2005-09-22 |
2008-12-18 |
Takeda Chem Ind Ltd |
Grk阻害剤からなる強心薬
|
US7776859B2
(en)
|
2005-10-14 |
2010-08-17 |
Bristol-Myers Squibb Company |
Hexahydroimidazopyrazin-3-one compounds useful as modulators of androgen receptor function
|
CA2629193C
(en)
|
2005-11-18 |
2016-03-29 |
3M Innovative Properties Company |
Coatable compositions, coatings derived therefrom and microarrays having such coatings
|
TW200730505A
(en)
|
2005-12-07 |
2007-08-16 |
Merck & Co Inc |
Polymorphs of an androgen receptor modulator
|
US8632801B2
(en)
|
2005-12-28 |
2014-01-21 |
Alza Corporation |
Stable therapeutic formulations
|
AU2007208139B2
(en)
|
2006-01-24 |
2012-09-27 |
Janssen Pharmaceutica N.V. |
2-substituted benzimidazoles as selective androgen receptor modulators (sarms)
|
EP1991523B1
(en)
|
2006-03-03 |
2012-08-15 |
Orion Corporation |
Selective androgen receptor modulators
|
WO2007106597A2
(en)
|
2006-03-15 |
2007-09-20 |
Alza Corporation |
Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
|
US9119945B2
(en)
|
2006-04-20 |
2015-09-01 |
3M Innovative Properties Company |
Device for applying a microneedle array
|
CA2656067C
(en)
*
|
2006-06-23 |
2014-08-12 |
Radius Health, Inc. |
Treatment of vasomotor symptoms with selective estrogen receptor modulators
|
PL2038252T3
(pl)
|
2006-07-12 |
2017-03-31 |
University Of Tennessee Research Foundation |
Podstawione acyloanilidy i sposoby ich zastosowania
|
BRPI0713200A2
(pt)
|
2006-07-19 |
2012-04-10 |
Osurf Ohio State University Res Foundation |
moduladores seletivos de receptores de androgênio, seus análogos e derivados, e seus usos
|
EA016853B1
(ru)
|
2006-08-24 |
2012-08-30 |
Юниверсити Оф Теннесси Рисерч Фаундейшн |
Замещенные ациланилиды и их применение
|
JP5275236B2
(ja)
|
2006-09-29 |
2013-08-28 |
スミスクライン ビーチャム コーポレーション |
置換されたインドール化合物
|
US7803770B2
(en)
|
2006-10-03 |
2010-09-28 |
Radius Health, Inc. |
Method of treating osteoporosis comprising administration of PTHrP analog
|
DK2957278T3
(en)
|
2006-10-03 |
2017-07-31 |
Radius Health Inc |
STABLE COMPOSITION COMPREHENSIVE PTHRP AND APPLICATIONS THEREOF
|
WO2008044033A1
(en)
|
2006-10-11 |
2008-04-17 |
Astrazeneca Ab |
Amide derivatives
|
UA98777C2
(en)
|
2006-11-20 |
2012-06-25 |
Эли Лилли Энд Компани |
Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators
|
WO2008121602A1
(en)
|
2007-03-29 |
2008-10-09 |
Smithkline Beecham Corporation |
Chemical compounds
|
WO2008124000A2
(en)
|
2007-04-02 |
2008-10-16 |
Ligand Pharmaceuticals Incorporated |
Thiazole derivatives as androgen receptor modulator compounds
|
US9284345B2
(en)
|
2007-04-12 |
2016-03-15 |
Endorecherche, Inc. |
17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators
|
WO2008128100A1
(en)
|
2007-04-13 |
2008-10-23 |
The Regents Of The University Of California |
Small-molecule inhibitors of the androgen receptor
|
AU2008241470B2
(en)
|
2007-04-16 |
2013-11-07 |
Corium Pharma Solutions, Inc. |
Solvent-cast microneedle arrays containing active
|
KR20100049644A
(ko)
|
2007-08-07 |
2010-05-12 |
다케다 야쿠힌 고교 가부시키가이샤 |
안드로겐 수용체 조절제로서의 피롤리딘-2-온 유도체
|
WO2009054988A1
(en)
|
2007-10-23 |
2009-04-30 |
Alza Corporation |
Transdermal sustained release drug delivery
|
EP2277124B1
(en)
|
2007-11-21 |
2016-11-09 |
Medizinische Hochschule Hannover |
Means for treating myosin-related diseases
|
PE20091157A1
(es)
|
2007-12-21 |
2009-09-03 |
Astrazeneca Ab |
Derivados biciclicos para usar en el tratamiento de afecciones asociadas con el receptor de androgeno - 155
|
US8067448B2
(en)
|
2008-02-22 |
2011-11-29 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
US8268872B2
(en)
|
2008-02-22 |
2012-09-18 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
WO2009133861A1
(ja)
|
2008-04-28 |
2009-11-05 |
武田薬品工業株式会社 |
環状アミン化合物
|
WO2009137104A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Radius Health, Inc. |
Combination therapy for breastcancer comprising an antiestrogenic agent
|
US8486943B2
(en)
|
2008-05-16 |
2013-07-16 |
Eli Lilly And Company |
Tetrahydrocyclopenta[b]indole androgen receptor modulators
|
WO2010022176A1
(en)
|
2008-08-19 |
2010-02-25 |
Ferring International Center S.A. |
Methods of treatment for skeletal conditons
|
ES2548378T3
(es)
|
2008-11-04 |
2015-10-16 |
Aska Pharmaceutical Co., Ltd. |
Composición acuosa que contiene hormona foliculoestimulante
|
WO2010074239A1
(ja)
|
2008-12-26 |
2010-07-01 |
久光製薬株式会社 |
マイクロニードルデバイス
|
US20100226966A1
(en)
|
2009-03-03 |
2010-09-09 |
Daddona Peter E |
Method for transdermal controlled release drug delivery
|
WO2010118287A1
(en)
|
2009-04-10 |
2010-10-14 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
KR101844080B1
(ko)
|
2009-10-16 |
2018-03-30 |
가부시키가이샤 한도오따이 에네루기 켄큐쇼 |
액정 표시 장치 및 이를 구비한 전자 장치
|
US20110172609A1
(en)
|
2010-01-08 |
2011-07-14 |
Ratio, Inc. |
Microneedle component assembly for drug delivery device
|
CA2788907A1
(en)
|
2010-02-04 |
2011-08-11 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
IE20100174A1
(en)
|
2010-03-25 |
2012-02-29 |
Trinity College Dublin |
Transdermal administration of peptides
|
AU2011248108B2
(en)
|
2010-05-04 |
2016-05-26 |
Corium Pharma Solutions, Inc. |
Method and device for transdermal delivery of parathyroid hormone using a microprojection array
|
CA2799183A1
(en)
|
2010-05-12 |
2011-11-17 |
Radius Health, Inc. |
Therapeutic regimens
|
CA2800253C
(en)
|
2010-05-28 |
2022-07-12 |
3M Innovative Properties Company |
Aqueous formulations for coating microneedle arrays
|
US8642632B2
(en)
|
2010-07-02 |
2014-02-04 |
Radius Health, Inc. |
Selective androgen receptor modulators
|
AU2011312490B2
(en)
|
2010-09-28 |
2015-06-25 |
Radius Pharmaceuticals, Inc. |
Selective androgen receptor modulators
|
WO2012075375A1
(en)
|
2010-12-02 |
2012-06-07 |
Lanco Biosciences, Inc. |
Delivery of parathyroid hormones by microinjection systems
|
AU2012245301B2
(en)
|
2011-04-22 |
2016-05-19 |
3M Innovative Properties Company, A Wholly Owned Subsidiary Of 3M Company |
Method of drug delivery for PTH, PTHrP and related peptides
|
CN104080441B
(zh)
|
2011-11-30 |
2020-02-28 |
3M创新有限公司 |
包括肽治疗剂和氨基酸的微针装置、制备和使用其的方法
|